Patents by Inventor Bart De Moor

Bart De Moor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11790629
    Abstract: The present invention relates generally to a species (analyte) separation and analysis system, for instance a spectrometry system, comprising a processor for receiving and processing signals from said its detector to remove undesirable variation or noise before further processing into a spectrum, whereby the processor is programmed by a novel program for a normalization preprocessing of the signals of said separation and analysis system.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: October 17, 2023
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Bart De Moor, Raf Van De Plas, Etienne Waelkens
  • Patent number: 10540536
    Abstract: Imaging mass spectrometry (IMS) has become a prime tool for studying the distribution of biomolecules in tissue. Although IMS data sets can become very large, computational methods have made it practically feasible to search these experiments for relevant findings. However, these methods lack access to an important source of information that many human interpretations rely upon: anatomical insight. In this work, this need is addressed by (1) integrating a curated anatomical data source with an empirically acquired IMS data source, establishing an algorithm-accessible link between them; and (2) demonstrating the potential of such an IMS-anatomical atlas link by applying it toward automated anatomical interpretation of ion distributions in tissue.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: January 21, 2020
    Assignees: Katholieke Universiteit Leuven, K.U.Leuven R&D, Vanderbilt University
    Inventors: Richard M. Caprioli, Bart De Moor, Raf Van De Plas, Nico Verbeeck, Etienne Waelkens
  • Publication number: 20190236397
    Abstract: The present invention relates generally to a species (analyte) separation and analysis system, for instance a spectrometry system, comprising a processor for receiving and processing signals from said its detector to remove undesirable variation or noise before further processing into a spectrum, whereby the processor is programmed by a novel program for a normalization preprocessing of the signals of said separation and analysis system.
    Type: Application
    Filed: April 10, 2019
    Publication date: August 1, 2019
    Inventors: Bart DE MOOR, Raf VAN DE PLAS, Etienne WAELKENS
  • Patent number: 10268916
    Abstract: The present invention relates generally to a species (analyte) separation and analysis system, for instance a spectrometry system, comprising a processor for receiving and processing signals from said its detector to remove undesirable variation or noise before further processing into a spectrum, whereby the processor is programmed by a novel program for a normalization preprocessing of the signals of said separation and analysis system.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: April 23, 2019
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Bart De Moor, Raf Van De Plas, Etienne Waelkens
  • Publication number: 20170220850
    Abstract: Imaging mass spectrometry (IMS) has become a prime tool for studying the distribution of biomolecules in tissue. Although IMS data sets can become very large, computational methods have made it practically feasible to search these experiments for relevant findings. However, these methods lack access to an important source of information that many human interpretations rely upon: anatomical insight. In this work, this need is addressed by (1) integrating a curated anatomical data source with an empirically acquired IMS data source, establishing an algorithm-accessible link between them; and (2) demonstrating the potential of such an IMS-anatomical atlas link by applying it toward automated anatomical interpretation of ion distributions in tissue.
    Type: Application
    Filed: August 3, 2015
    Publication date: August 3, 2017
    Inventors: Richard M. Caprioli, Bart De Moor, Raf Van De Plas, Nico Verbeeck, Etienne Waelkens
  • Patent number: 9328031
    Abstract: The present invention relates to a fertilizer composition comprising ammonium nitrate, of which the potential misuse as a precursor for an explosive is limited on the one hand, without hampering its legitimate use by farmers for food production on the other hand, to a method for the preparation of said fertilizer composition, and to the use thereof. The fertilizer composition comprising ammonium nitrate comprises a non-hygroscopic agent which is able to form a non-hygroscopic fertilizer composition with ammonium nitrate under normal conditions of storage and use, and to form an hygroscopic composition with ammonium nitrate after said fertilizer composition is contacted with water, and optionally a foaming agent. According to one embodiment, the non-hygroscopic agent is selected from the group of non-hygroscopic urea double salts, in particular urea calcium nitrate (UCaN).
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: May 3, 2016
    Assignee: YARA INTERNATIONAL ASA
    Inventors: Francois Ledoux, Bart De Moor
  • Publication number: 20150218058
    Abstract: The present invention relates to a fertilizer composition comprising ammonium nitrate, of which the potential misuse as a precursor for an explosive is limited on the one hand, without hampering its legitimate use by farmers for food production on the other hand, to a method for the preparation of said fertilizer composition, and to the use thereof. The fertilizer composition comprising ammonium nitrate comprises a non-hygroscopic agent which is able to form a non-hygroscopic fertilizer composition with ammonium nitrate under normal conditions of storage and use, and to form an hygroscopic composition with ammonium nitrate after said fertilizer composition is contacted with water, and optionally a foaming agent. According to one embodiment, the non-hygroscopic agent is selected from the group of non-hygroscopic urea double salts, in particular urea calcium nitrate (UCaN).
    Type: Application
    Filed: August 28, 2013
    Publication date: August 6, 2015
    Inventors: Francois Ledoux, Bart De Moor
  • Publication number: 20130035867
    Abstract: The present invention relates generally to a species (analyte) separation and analysis system, for instance a spectrometry system, comprising a processor for receiving and processing signals from said its detector to remove undesirable variation or noise before further processing into a spectrum, whereby the processor is programmed by a novel program, for a normalization preprocessing of the signals of said separation and analysis system.
    Type: Application
    Filed: April 12, 2011
    Publication date: February 7, 2013
    Applicant: Katholieke Universiteit Leuven K.U. Leuven R & D,
    Inventors: Bart De Moor, Raf Van De Plas, Etienne Waelkens
  • Publication number: 20120053083
    Abstract: Present invention concerns a kit and an in vitro method, for evaluating a biological stage of an HCC tumour in an individual, based on a sample from the individual, comprising: deriving from the sample a profile data set, the profile data set on a the gene expression panel with the markers CCNG2, EGLN3, ERO1L, FGF21, MAT1A, RCL1 and WDR45L or a substantially similar marker, being a quantitative measure of the amount of a distinct RNA or protein constituent in the panel so that measurement of the constituents enables evaluation of the biological condition or the biological behaviour HCC tumours.
    Type: Application
    Filed: May 5, 2010
    Publication date: March 1, 2012
    Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Anneleen Daemen, Bart De Moor, Olivier Gevaert, Louis Libbrecht, Hannah Van Malenstein, Jos Van Pelt, Chris Verslype
  • Patent number: 7491187
    Abstract: Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.
    Type: Grant
    Filed: March 24, 2003
    Date of Patent: February 17, 2009
    Assignee: K.U. Leuven Research & Development
    Inventors: Greta Van Den Berghe, Daniel Berckmans, Jean-Marie Aerts, Bart De Moor, Bert Pluymers, Frank De Smet
  • Publication number: 20050171503
    Abstract: Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.
    Type: Application
    Filed: March 24, 2003
    Publication date: August 4, 2005
    Inventors: Greta Van Den Berghe, Daniel Berckmans, Jean-Marie Aerts, Bart De Moor, Bert Pluymers, Frank De Smet